methamphetamine has been researched along with fr 121196 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
Kuratani, K; Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
Matsuoka, N; Satoh, M; Yamaguchi, I | 1 |
3 other study(ies) available for methamphetamine and fr 121196
Article | Year |
---|---|
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
Topics: Aging; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Dementia; Discrimination Learning; Disease Models, Animal; Male; Memory Disorders; Methamphetamine; Motor Activity; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Scopolamine; Sulfonamides | 1992 |
FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze.
Topics: Age Factors; Animals; Brain; Cholinergic Fibers; Ibotenic Acid; Male; Maze Learning; Memory; Methamphetamine; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Scopolamine; Space Perception; Sulfonamides | 1995 |
Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer.
Topics: Animals; Catecholamines; Cognition; Cysteamine; Electrophysiology; Guinea Pigs; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Methamphetamine; Nerve Fibers; Neural Pathways; Physostigmine; Piperazines; Scopolamine; Somatostatin; Sulfonamides | 1993 |